Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

The global race to harness the power of artificial intelligence (AI) has begun. President Donald Trump got it right from the ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Human Capital development is undergoing a radical transformation as Artificial Intelligence (AI) continues to evolve and ...

Strategic and disciplined execution underway to embed Bitcoin-backed capital into Rezolve’s AI commerce platform through ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

AI isn't replacing lawyers, but lawyers who effectively leverage AI will increasingly outpace those who don't.

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...